EUVIMEDEUVIMED entdecken
Crossref

Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs

Liangjie Sun, Xiaolei Gao, Meng Wang, Yixin Zhang, Ruiqing Sun, Yang Chen, Yan Bai, Yi Li, Lan Luo, Chong Ding, Yixiang Wang

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.217854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Liangjie Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Or…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Cyclin D1, Colorectal Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Nature Science Foundation of Beijing Municipality, Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The role of p53 deficiency or mutation in regulating nonhistone protein crotonylation and its impact on cancer development remain unclear. The present study identified crotonylation as a therapeutic target in patients with p53 deficiency or mutation in colorectal cancer. Crotonylome analysis revealed that p53 deficiency upregulated heterogeneous nuclear ribonucleoprotein C (HNRNPC) and HNRNPCK189Cr, promoting colorectal cancer cell proliferation by stabilizing CCND1 and MCM3 mRNAs through the MDM2/HDAC3 axis. Functional studies using HNRNPCK189Q (activating mutation) and HNRNPCK189R (inactivating mutation) confirmed the role of HNRNPCK189Cr in tumor growth. HDAC3 was identified as a specific decrotonylase of HNRNPCK189Cr. Sodium phytate, an HDAC3 agonist, effectively decrotonylated HNRNPCK189Cr and, in combination with HNRNPC siRNA, significantly inhibited the in vitro and in vivo growth of HCT116 p53-/- cells. An AOM/DSS-induced colorectal cancer model in K14-cre; p53 fl/fl mice validated the role of the p53/MDM2/HDAC3/HNRNPCK189Cr axis in tumor progression. Additionally, the findings in the oral cancer cells WSU-HN6 and non-small lung cancer cells H1299 were in line with those in the HCT116 cells, suggesting that the p53/MDM2/HDAC3/HNRNPCK189Cr regulatory mechanism plays a key role in a conserved manner. These findings revealed a novel mechanism by which p53 deficiency or mutation drives tumor progression via HNRNPCK189Cr through MDM2/HDAC3 axis-mediated CCND1 and MCM3 mRNA stability. Targeting HNRNPC and its crotonylation with sodium phytate and HNRNPC siRNA offers a promising therapeutic strategy, potentially converting p53 from an "undruggable" target to a "druggable" target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Cyclin D1Colorectal NeoplasmsHumansAnimalsMiceCell ProliferationHCT116 CellsRNA, MessengerHistone DeacetylasesGene Expression Regulation, NeoplasticProto-Oncogene Proteins c-mdm2Cell Line, TumorHistone Deacetylase 3

Stichwörter der Autor:innen

CrotonylationHDAC3HNRNPCmRNA stabilityp53 deficiencyp53 mutation

Substanzen

Tumor Suppressor Protein p53Cyclin D1RNA, MessengerHistone DeacetylasesProto-Oncogene Proteins c-mdm2Histone Deacetylase 3TP53 protein, humanCCND1 protein, humanMDM2 protein, human

Autor:innen und Institutionen

  • Central Laboratory, Peking University School and Hospital of Stomatology & National Center for Stomatology & National Clinical Research Center for Oral Diseases & National Engineering Research Center of Oral Biomaterial…
  • Department of Stomatology, Beijing Tongren Hospital, Capital medical University, Beijing, China.
  • Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, China.
  • Department of General Dentistry II, Peking University School and Hospital of Stomatology, Beijing, China.
  • Department of Pediatric Dentistry, Peking University School and Hospital of Stomatology, Beijing, China.
  • Shanxi Medical University School and Hospital of Stomatology, Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Taiyuan, China.

Förderung

  • Nature Science Foundation of Beijing Municipality
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation-Daxing Innovation Joint Fund Project

Zitieren

APA

Sun, L., Gao, X., Wang, M., Zhang, Y., Sun, R., Chen, Y., Bai, Y., Li, Y., Luo, L., Ding, C., & Wang, Y. (2025). Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217854

Vancouver

Sun L, Gao X, Wang M, Zhang Y, Sun R, Chen Y, et al. Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217854

BibTeX
@article{Sun2025,
  author = {Sun, Liangjie and Gao, Xiaolei and Wang, Meng and Zhang, Yixin and Sun, Ruiqing and Chen, Yang and Bai, Yan and Li, Yi and Luo, Lan and Ding, Chong and Wang, Yixiang},
  title = {Gobal crotonylome reveals that HNRNPC and its crotonylation promote p53-deficient tumor growth by stabilizing CCND1 and MCM3 mRNAs},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.217854}
}
Kostenlos starten →